(Journal Article): Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP
IN:
Diabetes Care
2003; 26:2628-2631
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)